321 related articles for article (PubMed ID: 15522068)
1. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion.
Verholen F; Stalder M; Helg C; Chalandon Y
Eur J Haematol; 2004 Dec; 73(6):441-6. PubMed ID: 15522068
[TBL] [Abstract][Full Text] [Related]
2. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
[TBL] [Abstract][Full Text] [Related]
4. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
[TBL] [Abstract][Full Text] [Related]
5. Resistant pure red cell aplasia after allogeneic bone marrow transplantation with major ABO mismatch treated by purified CD34+ cell infusion.
Woo HY; Min CK; Lee SM; Cho HS; Kim SY; Lee S; Lee JW; Min WS; Kim CC; Kim Y
Eur J Haematol; 2006 Feb; 76(2):160-3. PubMed ID: 16405438
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia.
Maschan AA; Skorobogatova EV; Balashov DN; Pashanov ED; Trakhtman PE; Schipitzina IP; Skvortsova YV; Rumiantzev AG
Bone Marrow Transplant; 2002 Sep; 30(6):405-7. PubMed ID: 12235527
[TBL] [Abstract][Full Text] [Related]
8. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Zhu KE; Li JP; Zhang T; Zhong J; Chen J
Hematology; 2007 Apr; 12(2):117-21. PubMed ID: 17454192
[TBL] [Abstract][Full Text] [Related]
10. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
[TBL] [Abstract][Full Text] [Related]
11. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption.
Rabitsch W; Knöbl P; Prinz E; Keil F; Greinix H; Kalhs P; Worel N; Jansen M; Hörl WH; Derfler K
Bone Marrow Transplant; 2003 Nov; 32(10):1015-9. PubMed ID: 14595389
[TBL] [Abstract][Full Text] [Related]
12. [Pure red cell aplasia after allogeneic peripheral blood stem cell transplantation: a case report and literature review].
Li C; Han M; Feng S
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):359-61. PubMed ID: 11721433
[TBL] [Abstract][Full Text] [Related]
13. [Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation].
Huang XJ; Liu DH; Xu LP; Han W; Jiang Q; Chen YH; Zhang YC; Liu KY; Bao L; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):548-50. PubMed ID: 16468333
[TBL] [Abstract][Full Text] [Related]
14. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team.
Ohashi K; Akiyama H; Takamoto S; Tanikawa S; Sakamaki H; Onozawa Y
Bone Marrow Transplant; 1994 Mar; 13(3):335-6. PubMed ID: 8199576
[TBL] [Abstract][Full Text] [Related]
15. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
[TBL] [Abstract][Full Text] [Related]
16. [ABO incompatibility and non myeloablative allogeneic stem cell transplantation].
Malfuson JV; Hicheri Y; Bonin P; Rodet M; Boccaccio C; Pautas C; Kuentz M; Cordonnier C; Noizat-Pirenne F; Maury S
Transfus Clin Biol; 2007 Aug; 14(3):327-33. PubMed ID: 17462938
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem cell transplantation from major ABO-incompatible donors.
Hirokawa M; Fukuda T; Ohashi K; Hidaka M; Ichinohe T; Iwato K; Kanamori H; Murata M; Sakura T; Imamura M; Adachi S; Suzuki R; Morishima Y; Sakamaki H;
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1026-32. PubMed ID: 23583828
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease.
Yamaguchi M; Sakai K; Murata R; Ueda M
Bone Marrow Transplant; 2002 Oct; 30(8):539-41. PubMed ID: 12379896
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation.
Fang B; Song Y; Li N; Li J; Han Q; Zhao RC
Ann Hematol; 2009 Mar; 88(3):261-6. PubMed ID: 18769919
[TBL] [Abstract][Full Text] [Related]
20. Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO-incompatible allogeneic haematopoietic stem cell transplantation.
Malfuson JV; Amor RB; Bonin P; Rodet M; Boccaccio C; Pautas C; Kuentz M; Cordonnier C; Noizat-Pirenne F; Maury S
Vox Sang; 2007 Jan; 92(1):85-9. PubMed ID: 17181595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
